Assistance Publique - Hôpitaux de Paris: Acute Lung Injury trials

The registry lists 22 Acute Lung Injury studies with Assistance Publique - Hôpitaux de Paris as lead sponsor. 8 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 3Phase 3 1No phase 18(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Prevention of Lung Injury Induced by Mechanical Ventilation in Acute Respiratory Distress Syndrome ARDS PatientsNot yet recruitingNCT06835881
• VExUS in Ards Patients and Association with AKIRecruitingNCT06805409
• Driving Pressure-guided Tidal Volume Ventilation in the Acute Respiratory Distress SyndromeNot yet recruitingNCT06322758Not applicable
• Physiological Study of Prone Position in Acute Respiratory Failure SyndromeRecruitingNCT06061796Not applicable
• Paramedical Protocol for Ventilation in Acute Respiratory Distress SyndromeNot yet recruitingNCT06039215Not applicable
• Impact of COVID-19 SARS-CoV-2 Variability in ICU Hospitalized Patients With Severe DiseaseRecruitingNCT05162508
• Lessening Organ Dysfunction With VITamin C in Septic ARDSRecruitingNCT04404387Phase 3
• Albumin and Prognosis of Severely Patients BurnsRecruitingNCT04264065
• Factors and Prognosis of Obstructive Pyelonephritis PatientsCompletedNCT06299215
• Effects of Continuous Anterior Chest CompressionCompletedNCT05876468Not applicable
• Assessment of Cardiac Output in Patients With ARDS Implanted With Venous-venous ECMO.Status unknownNCT05164484Not applicable
• Effects of Blood Pulsatility on Von Willebrand Factor During ECCO2RCompletedNCT05079009Not applicable
• FX06 to Rescue Acute Respiratory Distress Syndrome During Covid-19 PneumoniaCompletedNCT04618042Phase 2
• PRONing to Facilitate Weaning From ECMO in Patients With Refractory Acute Respiratory Distress SyndromeCompletedNCT04607551Not applicable
• Coronavirus Studied by Metagenomics in ARDS COVID-19 PatientsStatus unknownNCT04516486
• Low Dose of IL-2 In Acute Respiratory DistrEss Syndrome Related to COVID-19CompletedNCT04357444Phase 2
• Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDSCompletedNCT04333368Phase 1/2
• Immune Alveolar Alterations During Pneumonia-Associated Acute Respiratory Distress SyndromeStatus unknownNCT03971006
• Correction by ECCO2-R of Hypercapnia in Patients With DVP in Moderate to Severe ARDS Under Protective Ventilation.CompletedNCT03303807Not applicable
• Validation of the Percentage of Alveolar Fibrocyte as Biomarker During ARDSCompletedNCT01854424
• Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress SyndromeCompletedNCT01470703Not applicable
• Effect of Positive Expiratory Pressure on Right Ventricular Function in Patients With Respiratory Distress SyndromeCompletedNCT00236262Not applicable